Replies to post #297322 on Avid Bioservices Inc (CDMO)

[The Other Guy]

Not much does. Except excuses to prolong BOD pay of $320,000 / year.

[biopharm]

I disagree.

. “We are extremely delighted at the opportunity to benefit from the experience and knowledge of each of these doctors, which will fortify our Immuno-Oncology and Stem Cell platforms,” said William (Wei) Cao, Chief Executive Officer for the Company. “Dr. Antonia is one of the foremost experts in the field of immuno-oncology and as a principal investigator of multiple high profile immuno-oncology clinical trials, including anti-PD-1 therapy for advanced lung cancer, has made significant strides with gene-modified tumor cell vaccine development. His research and experience in designing immunotherapy studies will no doubt advance our development of combination therapies for cancer, both in China and internationally.

http://www.cellbiomedgroup.com/newsroom/new-members-to-scientific-advisory-board/

I believe CBMG was targeted as Peregrine was ...and ask yourself why Peregrine KOL Scott Antonia decided to advise CBMG...

Read my original post and put the puzzle pieces together as you read the class action

Case3:15-cv-01795-WHO Document1 Filed04/21/15 Page1 of 23....

Now after you read the court case you see why CMBG pipeline is undisclosed ....(with PS Targeting IO combo I say)

Not to difficult to piece it altogether and now go back and read all the other biotech pipelines with undisclosed agents/targets...

[Bluerinse]

Well I guess we will see ...
Imo